ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
BeOne Medicines Ltd (ONC) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Expansion [Yahoo! Finance]
BeOne Medicines (ONC) had its price target raised by Truist Financial Corporation from $400.00 to $412.00. They now have a "buy" rating on the stock.
BeOne Medicines (ONC) had its price target raised by Guggenheim from $400.00 to $410.00. They now have a "buy" rating on the stock.
BeOne Medicines (ONC) had its price target raised by Barclays PLC from $394.00 to $405.00. They now have an "overweight" rating on the stock.
BeOne Medicines (ONC) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Form 4 BeOne Medicines Ltd. For: Feb 04 Filed by: Lee Chan Henry
Form 4 BeOne Medicines Ltd. For: Jan 07 Filed by: Lee Chan Henry
Form 4 BeOne Medicines Ltd. For: Dec 31 Filed by: Wang Lai
Form 4 BeOne Medicines Ltd. For: Dec 15 Filed by: OYLER JOHN
Form 4 BeOne Medicines Ltd. For: Dec 10 Filed by: Lee Chan Henry
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.